Submitted by web@researchtop... on Mon, 04/30/2012 - 11:08
Submitted by mphilemon@resea... on Fri, 04/20/2012 - 15:07
Submitted by mphilemon@resea... on Fri, 04/20/2012 - 14:57
Submitted by mphilemon@resea... on Fri, 04/20/2012 - 14:48
Submitted by mphilemon@resea... on Fri, 04/20/2012 - 14:41
Submitted by mphilemon@resea... on Fri, 04/20/2012 - 14:28
Submitted by mphilemon@resea... on Fri, 04/20/2012 - 14:24
Disclosures:
Submitted by web@researchtop... on Wed, 04/18/2012 - 15:36
Submitted by web@researchtop... on Wed, 04/18/2012 - 15:21
Submitted by web@researchtop... on Wed, 04/18/2012 - 15:19
Submitted by web@researchtop... on Fri, 04/06/2012 - 13:12
Submitted by web@researchtop... on Tue, 04/03/2012 - 15:23
Patterns of Care in Breast Cancer — Interactive Edition: Adjuvant chemotherapy for ER-positive, HER2-negative tumors
Submitted by web@researchtop... on Tue, 04/03/2012 - 10:22
Submitted by mphilemon@resea... on Wed, 03/28/2012 - 13:21
Submitted by web@researchtop... on Tue, 03/27/2012 - 16:23
References:
Ademuyiwa FO et al. The effects of Oncotype DX Recurrence Scores on chemotherapy utilization in a multi-institutional breast cancer cohort. Breast Cancer Res Treat 2011;126(3):797-802. Abstract